Douglas Richman
From Wikipedia, the free encyclopedia
Douglas D Richman, MD is a US medical virologist. Richman has worked primarily in the HIV field over the past twenty years, with major contributions in the areas of resistance and pathogenicity: he was one of the group of researchers who first demonstrated HIV drug resistance in 1989,[1] and in 1997, his laboratory was also among the first to demonstrate HIV latency.[2] His research in 2006 focuses on acute HIV infection.
As of 2006, he is Professor of Pathology and Medicine at the University of California San Diego (UCSD), where he holds the Florence Seeley Riford Chair in AIDS Research and is Director of the Center for AIDS Research. He is also Director of the Research Center for AIDS and HIV Infection at the VA San Diego Healthcare System.
He was one of the founding editors of the academic journal Antiviral Therapy, and is Editor-in-Chief of Topics in HIV Medicine and co-editor of the textbook Clinical Virology.[3]
[edit] Sources
- ^ Larder B, Darby G, Richman DD (1989) HIV with reduced sensitivity to zidovudine isolated during prolonged therapy. Science 243:1731-1734
- ^ Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA, Richman DD (1997) Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291-95
- ^ Richman DD, Whitley RJ, Hayden FG, eds. Clinical Virology (2nd edn) ASM Press, 2002